The Aspen Times7h
Decision on citizen petition to halt wolf introductions is still pending as CPW staff work on a recommendation
Colorado Parks and Wildlife Commission is asking for patience as it reviews a petition submitted by 26 groups asking the ...
Fintel on MSN10h
Wolfe Research Initiates Coverage of Moderna (MRNA) with Underperform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Moderna (NasdaqGS:MRNA) with a Underperform ...
U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
Wolfe projects a positive outlook for Pharma & Large-Cap Biotech stocks despite potential policy changes as part of Make America Healthy Again movement. Read more here.
Veracyte initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ...
Wolfe starts Grail at Peer Perform on time and money needs
As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Grail (GRAL) with a Peer Perform rating and no price target ...
bovnews18h
Wolfe Research Just Resumed ConocoPhillips (COP) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.09% of ...
bovnews19h
Wolfe Research Issues Peer Perform Rating for Warner Bros Discovery Inc (WBD) Stock
Wolfe Research has recently raised Warner Bros Discovery Inc (WBD) stock to Peer Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on August 13, 2024, Bernstein had ...
RFK pick poses uncertainty in areas of healthcare sector, says Wolfe Research's Marcus Tobin
Tobin Marcus, Wolfe Research policy and politics head, joins CNBC's 'Squawk Box' to discuss what Trump's pick for HHS ...